Blue Trust’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.7K Sell
1,357
-483
-26% -$11.7K ﹤0.01% 1361
2026
Q2
$44.6K Buy
1,840
+1,054
+134% +$25.5K ﹤0.01% 1389
2026
Q1
$19K Buy
786
+6
+0.8% +$146 ﹤0.01% 1665
2025
Q4
$18.9K Buy
780
+11
+1% +$267 ﹤0.01% 1704
2025
Q3
$18.7K Buy
769
+8
+1% +$194 ﹤0.01% 1683
2025
Q2
$18.5K Buy
761
+9
+1% +$217 ﹤0.01% 1702
2025
Q1
$18.2K Buy
752
+5
+0.7% +$120 ﹤0.01% 1671
2024
Q4
$17.9K Buy
+747
New +$18K ﹤0.01% 1636
2024
Q3
– Sell
-300
Closed -$7.14K – 2948
2024
Q2
$7.14K Hold
300
– – ﹤0.01% 2064
2024
Q1
$7.14K Buy
+300
New +$7.14K ﹤0.01% 1543

Other funds holding IBDS

Blue Trust's IBDS Position: Q3 2026 in Review

Blue Trust reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 26% in Q3 2026, selling an estimated $11.7K and leaving 1,357 shares worth $32.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1361.

Blue Trust first reported a position in IBDS in Q1 2024 and has held it in 10 quarters since. The position peaked at $44.6K in Q2 2026. 421 funds tracked by Wall St. Rank hold IBDS as of Q3 2026.

  • Blue Trust held 1,357 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $32.7K as of Q3 2026.
  • Blue Trust sold 483 iShares iBonds Dec 2027 Term Corporate ETF shares in Q3 2026, an estimated $11.7K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1361 holding.
  • Blue Trust first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • Blue Trust's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $44.6K in Q2 2026.
  • 421 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.